Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313442783> ?p ?o ?g. }
- W4313442783 endingPage "121324" @default.
- W4313442783 startingPage "121324" @default.
- W4313442783 abstract "Sustained-release systems reduce the incidence of drug side effects and the need for frequent drug consumption, thus increasing patient compliance with treatment. In this study, we aimed to produce sustained-release buprenorphine (BP) using lipid-liquid crystal gels.The three experimental groups in this study included: group I: lipid-liquid crystal formulation 5 (F5) containing BP, group II: BP-free F5, group III: BP solution in NMP, and group IV: control (no treatment). The formulations were injected subcutaneously into the rabbits' back neck.The results showed that the time required to reach the drug's maximum concentration (Tmax) was longer in group I than in group III. The maximum BP concentration (Cmax) and the constants of the drug removal rate and drug absorption rate (Ka) were significantly higher in group III compared to group I. The half-life (t1/2) of the drug in blood circulation was significantly longer in group I than in group III. Histopathological analysis revealed no histological abnormalities in the skin and heart in group I (BP-containing F5); however, mild hyperemia was observed in interstitial vessels in group III (BP-containing NMP). The kidney and liver tissues showed normal structure in the control group, as well as groups I and II. However, in the group receiving BP-containing NMP, significant congestion, tissue damage, necrosis, and fibrosis were observed in the kidney and liver.The results showed that the lipid-liquid crystal system can be used to design slow-release platforms for BP, minimizing the side effects associated with the use of its conventional forms." @default.
- W4313442783 created "2023-01-06" @default.
- W4313442783 creator A5025111633 @default.
- W4313442783 creator A5041243715 @default.
- W4313442783 creator A5046549815 @default.
- W4313442783 creator A5068435169 @default.
- W4313442783 creator A5080076536 @default.
- W4313442783 creator A5082111706 @default.
- W4313442783 creator A5083715779 @default.
- W4313442783 date "2023-02-01" @default.
- W4313442783 modified "2023-09-24" @default.
- W4313442783 title "In-vitro and in-vivo evaluation of sustained-release buprenorphine using in-situ forming lipid-liquid crystal gels" @default.
- W4313442783 cites W1966418546 @default.
- W4313442783 cites W1969932330 @default.
- W4313442783 cites W1981885001 @default.
- W4313442783 cites W2042584005 @default.
- W4313442783 cites W2055260855 @default.
- W4313442783 cites W2116611239 @default.
- W4313442783 cites W2141693380 @default.
- W4313442783 cites W2152653689 @default.
- W4313442783 cites W2488096490 @default.
- W4313442783 cites W2536753591 @default.
- W4313442783 cites W2570742509 @default.
- W4313442783 cites W2580042036 @default.
- W4313442783 cites W2596099200 @default.
- W4313442783 cites W2611978797 @default.
- W4313442783 cites W2747521040 @default.
- W4313442783 cites W2808504153 @default.
- W4313442783 cites W2810248278 @default.
- W4313442783 cites W2888824153 @default.
- W4313442783 cites W2889653025 @default.
- W4313442783 cites W2916034192 @default.
- W4313442783 cites W2944736729 @default.
- W4313442783 cites W2944856342 @default.
- W4313442783 cites W2953831619 @default.
- W4313442783 cites W2995404934 @default.
- W4313442783 cites W3024703937 @default.
- W4313442783 cites W3048673846 @default.
- W4313442783 cites W3087336923 @default.
- W4313442783 cites W3134340231 @default.
- W4313442783 cites W3139699149 @default.
- W4313442783 cites W3151104822 @default.
- W4313442783 cites W3164732278 @default.
- W4313442783 cites W3181310957 @default.
- W4313442783 cites W3200538727 @default.
- W4313442783 cites W3207378916 @default.
- W4313442783 cites W4214819075 @default.
- W4313442783 cites W4221124151 @default.
- W4313442783 cites W4235186041 @default.
- W4313442783 doi "https://doi.org/10.1016/j.lfs.2022.121324" @default.
- W4313442783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36574944" @default.
- W4313442783 hasPublicationYear "2023" @default.
- W4313442783 type Work @default.
- W4313442783 citedByCount "3" @default.
- W4313442783 countsByYear W43134427832023 @default.
- W4313442783 crossrefType "journal-article" @default.
- W4313442783 hasAuthorship W4313442783A5025111633 @default.
- W4313442783 hasAuthorship W4313442783A5041243715 @default.
- W4313442783 hasAuthorship W4313442783A5046549815 @default.
- W4313442783 hasAuthorship W4313442783A5068435169 @default.
- W4313442783 hasAuthorship W4313442783A5080076536 @default.
- W4313442783 hasAuthorship W4313442783A5082111706 @default.
- W4313442783 hasAuthorship W4313442783A5083715779 @default.
- W4313442783 hasConcept C112705442 @default.
- W4313442783 hasConcept C126322002 @default.
- W4313442783 hasConcept C150903083 @default.
- W4313442783 hasConcept C170493617 @default.
- W4313442783 hasConcept C185592680 @default.
- W4313442783 hasConcept C207001950 @default.
- W4313442783 hasConcept C22979827 @default.
- W4313442783 hasConcept C2778949969 @default.
- W4313442783 hasConcept C2780035454 @default.
- W4313442783 hasConcept C2780091579 @default.
- W4313442783 hasConcept C2781063702 @default.
- W4313442783 hasConcept C55493867 @default.
- W4313442783 hasConcept C71924100 @default.
- W4313442783 hasConcept C86803240 @default.
- W4313442783 hasConcept C98274493 @default.
- W4313442783 hasConceptScore W4313442783C112705442 @default.
- W4313442783 hasConceptScore W4313442783C126322002 @default.
- W4313442783 hasConceptScore W4313442783C150903083 @default.
- W4313442783 hasConceptScore W4313442783C170493617 @default.
- W4313442783 hasConceptScore W4313442783C185592680 @default.
- W4313442783 hasConceptScore W4313442783C207001950 @default.
- W4313442783 hasConceptScore W4313442783C22979827 @default.
- W4313442783 hasConceptScore W4313442783C2778949969 @default.
- W4313442783 hasConceptScore W4313442783C2780035454 @default.
- W4313442783 hasConceptScore W4313442783C2780091579 @default.
- W4313442783 hasConceptScore W4313442783C2781063702 @default.
- W4313442783 hasConceptScore W4313442783C55493867 @default.
- W4313442783 hasConceptScore W4313442783C71924100 @default.
- W4313442783 hasConceptScore W4313442783C86803240 @default.
- W4313442783 hasConceptScore W4313442783C98274493 @default.
- W4313442783 hasFunder F4320322855 @default.
- W4313442783 hasLocation W43134427831 @default.
- W4313442783 hasLocation W43134427832 @default.
- W4313442783 hasOpenAccess W4313442783 @default.
- W4313442783 hasPrimaryLocation W43134427831 @default.